These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
444 related articles for article (PubMed ID: 30051142)
1. Prognostic model based on magnetic resonance imaging, whole-tumour apparent diffusion coefficient values and HPV genotyping for stage IB-IV cervical cancer patients following chemoradiotherapy. Lin G; Yang LY; Lin YC; Huang YT; Liu FY; Wang CC; Lu HY; Chiang HJ; Chen YR; Wu RC; Ng KK; Hong JH; Yen TC; Lai CH Eur Radiol; 2019 Feb; 29(2):556-565. PubMed ID: 30051142 [TBL] [Abstract][Full Text] [Related]
2. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation. Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349 [TBL] [Abstract][Full Text] [Related]
3. Treatment response evaluation using the mean apparent diffusion coefficient in cervical cancer patients treated with definitive chemoradiotherapy. Onal C; Erbay G; Guler OC J Magn Reson Imaging; 2016 Oct; 44(4):1010-9. PubMed ID: 26919800 [TBL] [Abstract][Full Text] [Related]
4. Predicting tumor recurrence in patients with cervical carcinoma treated with definitive chemoradiotherapy: value of quantitative histogram analysis on diffusion-weighted MR images. Erbay G; Onal C; Karadeli E; Guler OC; Arica S; Koc Z Acta Radiol; 2017 Apr; 58(4):481-488. PubMed ID: 27445314 [TBL] [Abstract][Full Text] [Related]
5. Prognostic value of ADC quantification for clinical outcome in uterine cervical cancer treated with concurrent chemoradiotherapy. Gu KW; Kim CK; Choi CH; Yoon YC; Park W Eur Radiol; 2019 Nov; 29(11):6236-6244. PubMed ID: 30980126 [TBL] [Abstract][Full Text] [Related]
6. Whole lesion histogram analysis of apparent diffusion coefficients on MRI predicts disease-free survival in locally advanced squamous cell cervical cancer after radical chemo-radiotherapy. Zhao B; Cao K; Li XT; Zhu HT; Sun YS BMC Cancer; 2019 Nov; 19(1):1115. PubMed ID: 31729974 [TBL] [Abstract][Full Text] [Related]
7. Added-value of texture analysis of ADC in predicting the survival of patients with 2018 FIGO stage IIICr cervical cancer treated by concurrent chemoradiotherapy. Zhang X; Zhang Q; Guo J; Zhao J; Xie L; Zhang J; An J; Yu X; Zhao X Eur J Radiol; 2022 May; 150():110272. PubMed ID: 35334244 [TBL] [Abstract][Full Text] [Related]
8. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer. Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385 [TBL] [Abstract][Full Text] [Related]
9. Prognostic values of ADC Akkus Yildirim B; Onal C; Erbay G; Cem Guler O; Karadeli E; Reyhan M; Koc Z J Obstet Gynaecol; 2019 Feb; 39(2):224-230. PubMed ID: 30354907 [TBL] [Abstract][Full Text] [Related]
10. Diffusion-Weighted Magnetic Resonance Imaging as a Predictor of Outcome in Cervical Cancer After Chemoradiation. Ho JC; Allen PK; Bhosale PR; Rauch GM; Fuller CD; Mohamed AS; Frumovitz M; Jhingran A; Klopp AH Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):546-553. PubMed ID: 28011045 [TBL] [Abstract][Full Text] [Related]
11. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer. Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276 [TBL] [Abstract][Full Text] [Related]
12. Can diffusion-weighted magnetic resonance imaging predict tumor recurrence of uterine cervical cancer after concurrent chemoradiotherapy? Bae JM; Kim CK; Park JJ; Park BK Abdom Radiol (NY); 2016 Aug; 41(8):1604-10. PubMed ID: 27056747 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pre-treatment human papilloma virus DNA status in cervical cancer. Chong GO; Lee YH; Han HS; Lee HJ; Park JY; Hong DG; Lee YS; Cho YL Gynecol Oncol; 2018 Jan; 148(1):97-102. PubMed ID: 29153540 [TBL] [Abstract][Full Text] [Related]
14. HPV genotypes predict survival benefits from concurrent chemotherapy and radiation therapy in advanced squamous cell carcinoma of the cervix. Wang CC; Lai CH; Huang YT; Chao A; Chou HH; Hong JH Int J Radiat Oncol Biol Phys; 2012 Nov; 84(4):e499-506. PubMed ID: 22889667 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of diffusion-weighted magnetic resonance imaging and Park JJ; Kim CK; Park BK Radiother Oncol; 2016 Sep; 120(3):507-511. PubMed ID: 26900089 [TBL] [Abstract][Full Text] [Related]
16. Potentialities of multi-b-values diffusion-weighted imaging for predicting efficacy of concurrent chemoradiotherapy in cervical cancer patients. Liu B; Ma WL; Zhang GW; Sun Z; Wei MQ; Hou WH; Hou BX; Wei LC; Huan Y BMC Med Imaging; 2020 Aug; 20(1):97. PubMed ID: 32799809 [TBL] [Abstract][Full Text] [Related]
17. Added-value of dynamic contrast-enhanced MRI on prediction of tumor recurrence in locally advanced cervical cancer treated with chemoradiotherapy. Zhang Q; Guo J; Ouyang H; Chen S; Zhao X; Yu X Eur Radiol; 2022 Apr; 32(4):2529-2539. PubMed ID: 34647177 [TBL] [Abstract][Full Text] [Related]
18. Clinical implications of human papillomavirus genotype in cervical adeno-adenosquamous carcinoma. Lai CH; Chou HH; Chang CJ; Wang CC; Hsueh S; Huang YT; Chen YR; Chang HP; Chang SC; Lin CT; Chao A; Qiu JT; Huang KG; Chen TC; Jao MS; Chen MY; Liou JD; Huang CC; Chang TC; Patsner B Eur J Cancer; 2013 Feb; 49(3):633-41. PubMed ID: 23031554 [TBL] [Abstract][Full Text] [Related]
19. Early alteration in apparent diffusion coefficient and tumor volume in cervical cancer treated with chemoradiotherapy or radiotherapy: Incremental prognostic value over pretreatment assessments. Watanabe Y; Nakamura S; Ichikawa Y; Ii N; Kawamura T; Kondo E; Ikeda T; Nomoto Y; Sakuma H Radiother Oncol; 2021 Feb; 155():3-9. PubMed ID: 33039422 [TBL] [Abstract][Full Text] [Related]
20. Prediction of disease progression following concurrent chemoradiotherapy for uterine cervical cancer: value of post-treatment diffusion-weighted imaging. Park JJ; Kim CK; Park BK Eur Radiol; 2016 Sep; 26(9):3272-9. PubMed ID: 26685853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]